Variant report
Variant | nsv508300 |
---|---|
Chromosome Location | chr4:103858036-103876829 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOXA1 | chr4:103861442-103861685 | T-47D | breast: | n/a | n/a |
2 | IRF1 | chr4:103867305-103867323 | K562 | blood: | n/a | n/a |
3 | JUND | chr4:103869676-103869893 | HepG2 | liver: | n/a | n/a |
4 | SIN3AK20 | chr4:103859180-103859367 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | SIX5 | chr4:103859542-103859743 | K562 | blood: | n/a | n/a |
6 | SIX5 | chr4:103861745-103861943 | K562 | blood: | n/a | n/a |
7 | SPI1 | chr4:103876653-103876937 | GM12878 | blood: | n/a | chr4:103876797-103876810 |
8 | SPI1 | chr4:103863539-103863775 | GM12891 | blood: | n/a | n/a |
9 | SPI1 | chr4:103876677-103876903 | GM12891 | blood: | n/a | chr4:103876797-103876810 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:103867628-103867678 | HRPEpiC | eye: | n/a |
2 | chr4:103867628-103867678 | HPAEpiC | pulmonary alveolar: | n/a |
3 | chr4:103867628-103867678 | NHDF-neo | bronchial: | n/a |
4 | chr4:103867628-103867678 | Hepatocyte | liver: | n/a |
5 | chr4:103867628-103867678 | Hela-S3 | cervix: | n/a |
6 | chr4:103867628-103867678 | HNPCEpiC | eye: | n/a |
7 | chr4:103867628-103867678 | HRE | kidney: | n/a |
8 | chr4:103867628-103867678 | ECC-1 | luminal epithelium: | n/a |
9 | chr4:103867628-103867678 | AoSMC | blood vessel: | n/a |
10 | chr4:103867628-103867678 | SK-N-MC | brain: | n/a |
11 | chr4:103867628-103867678 | H1-hESC | embryonic stem cell: | embryo |
12 | chr4:103867628-103867678 | T-47D | breast: | n/a |
13 | chr4:103867628-103867678 | HEEpiC | esophagus: | n/a |
14 | chr4:103867628-103867678 | Caco-2 | colon: | n/a |
15 | chr4:103867628-103867678 | AG04450 | lung: | fetal |
16 | chr4:103867628-103867678 | AG10803 | skin: | n/a |
17 | chr4:103867628-103867678 | GM12892 | blood: | n/a |
18 | chr4:103867628-103867678 | GM12891 | blood: | n/a |
19 | chr4:103867628-103867678 | Jurkat | blood: | n/a |
20 | chr4:103867628-103867678 | SK-N-SH | brain: | n/a |
21 | chr4:103867628-103867678 | HMEC | breast: | n/a |
22 | chr4:103867628-103867678 | SK-N-SH_RA | brain: | n/a |
23 | chr4:103867628-103867678 | HCPEpiC | choroid plexus: | n/a |
24 | chr4:103867628-103867678 | HCF | heart: | n/a |
25 | chr4:103867628-103867678 | NB4 | blood: | n/a |
26 | chr4:103867628-103867678 | SKMC | muscle: | n/a |
27 | chr4:103867628-103867678 | HRCEpiC | kidney: | n/a |
28 | chr4:103867628-103867678 | MCF-7 | breast: | n/a |
29 | chr4:103867628-103867678 | HIPEpiC | eye: | n/a |
30 | chr4:103867628-103867678 | ProgFib | skin: | n/a |
31 | chr4:103867628-103867678 | SAEC | small airway: | n/a |
32 | chr4:103867628-103867678 | BJ | skin: | n/a |
33 | chr4:103867628-103867678 | HEK293 | kidney: | embryo |
34 | chr4:103867628-103867678 | AG09309 | skin: | n/a |
35 | chr4:103867628-103867678 | HepG2 | liver: | n/a |
36 | chr4:103867628-103867678 | PrEC | prostate: | n/a |
37 | chr4:103867628-103867678 | AG04449 | skin: | fetal |
38 | chr4:103867628-103867678 | NHBE | bronchial: | n/a |
39 | chr4:103867628-103867678 | U87 | brain: | n/a |
40 | chr4:103867628-103867678 | GM19239 | blood: | n/a |
41 | chr4:103867628-103867678 | HCT-116 | colon: | n/a |
42 | chr4:103867628-103867678 | GM06990 | blood: | n/a |
43 | chr4:103867628-103867678 | HL-60 | blood: | n/a |
44 | chr4:103867628-103867678 | GM12878 | blood: | n/a |
45 | chr4:103867628-103867678 | PANC-1 | pancreas: | n/a |
46 | chr4:103867628-103867678 | IMR90 | lung: | fetal |
47 | chr4:103867628-103867678 | HCM | heart: | n/a |
48 | chr4:103867628-103867678 | A549 | lung: | n/a |
49 | chr4:103867628-103867678 | MCF10A-Er-Src | breast: | n/a |
50 | chr4:103867628-103867678 | NT2-D1 | testis: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:103876539..103878072-chr4:103939783..103942187,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC9B1 | TF binding region |
SLC9B1 | CpG island |
ENSG00000164037 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549205637 | chr4:103859036-103859037 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4530634 | chr4:103859081-103859082 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs145500429 | chr4:103859083-103859084 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546538855 | chr4:103859090-103859091 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189891215 | chr4:103859094-103859095 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539726094 | chr4:103859107-103859108 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558078888 | chr4:103859114-103859115 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569908022 | chr4:103859161-103859162 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537208632 | chr4:103859176-103859177 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143441157 | chr4:103859203-103859204 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571309714 | chr4:103859263-103859264 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7676943 | chr4:103859292-103859293 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs371854385 | chr4:103859301-103859302 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553308836 | chr4:103859361-103859362 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141904443 | chr4:103859398-103859399 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4446311 | chr4:103859401-103859402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs181781805 | chr4:103859402-103859403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201785589 | chr4:103859444-103859445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6533039 | chr4:103859538-103859539 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs138794367 | chr4:103859545-103859546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201286114 | chr4:103859555-103859556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560938090 | chr4:103859579-103859580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528171679 | chr4:103859592-103859593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568062876 | chr4:103871809-103871810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367698491 | chr4:103871816-103871817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553817815 | chr4:103871831-103871832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573560771 | chr4:103871917-103871918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372174665 | chr4:103871952-103871953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562982408 | chr4:103871960-103871961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559194208 | chr4:103871976-103871977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577408076 | chr4:103872012-103872013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs13152518 | chr4:103872021-103872022 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs562956864 | chr4:103872049-103872050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530160453 | chr4:103872058-103872059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541789590 | chr4:103872108-103872109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551880136 | chr4:103872155-103872156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189231389 | chr4:103872167-103872168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200384028 | chr4:103872178-103872179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111409015 | chr4:103872188-103872189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183120504 | chr4:103872200-103872201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539576688 | chr4:103876549-103876550 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs558128759 | chr4:103876570-103876571 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs72937424 | chr4:103876589-103876590 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs144702768 | chr4:103876600-103876601 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs372449535 | chr4:103876609-103876610 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs561789187 | chr4:103876613-103876614 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs6830193 | chr4:103876614-103876615 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs541196303 | chr4:103876629-103876630 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs199903570 | chr4:103876675-103876676 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs200855365 | chr4:103876686-103876687 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
myeloid cancer | 21057493 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:103859000-103859200 | Enhancers | H1 Cell Line | embryonic stem cell |
2 | chr4:103859000-103859200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr4:103859000-103859400 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
4 | chr4:103859000-103859400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr4:103859000-103859600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr4:103859000-103859600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr4:103871800-103872200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |